IIT Delhi & AIIMS Jointly Invite Applications for ‘iFellowship’

Eligible candidates can register online for iFellowship on the official website,

1 min read
Image used for representation only.

School of International Biodesign (SiB) -- jointly operated by the Indian Institute of Technology (IIT) Delhi and the All India Institute of Medical Sciences (AIIMS) New Delhi -- has invited online applications for its fellowship programme in medical programme or ‘iFellowship’.

iFellows will be mentored by faculty members from AIIMS, New Delhi, IIT Delhi, MedTech Industry, start-ups, academia, and hospitals. The program also offers post-fellowship support to promising innovators.

School of International Biodesign (SiB) is a flagship program of the Department of Biotechnology, Ministry of Science and Technology, Government of India, administered in collaboration between AIIMS New Delhi and IIT Delhi. The institute is based at AIIMS, New Delhi.

What are Eligibility Requirements of iFellowship?

Candidates with undergraduate (UG) or postgraduate (PG) degrees in Medicine, Engineering, Design, and Business are eligible to apply for iFellowship. In the selection process, preference will be given to “candidates who have demonstrated a track record of innovation, passion for entrepreneurship and are willing to work in a team to create social impact through innovative product realisation and commercialisation.”

Eligible candidates can register online for iFellowship on the official website,

What is the Duration of iFellowship?

The duration of the fellowship is one year, starting from March, 2021. Shortlisted candidates will be called for the interview round in February.

Does the iFellowship Program Offer any Stipends?

iFellows are offered a consolidated stipend of Rs 60,000 per month. Other benefits include travel costs and health coverage.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!